Research Labs & Facilities
The Department of Pediatrics houses multiple research labs within the many research facilities in the UF Health Science Center.
Pediatric Research Labs & Centers
The focus of Dr. Boye’s lab is developing viral vector-based gene replacement strategies for the treatment of inherited ocular disease.
We research how the nervous system works and how it responds and repairs itself due to the damage caused by injury or disease. Our two main goals are to: Discover strategies for enhancing neuronal regrowth and staling neuronal loss after injury, and understand the nervous system response and recovery during damage caused by disease.
Dr. Hoffman is an Associate Professor and cellular immunologist with a major interest in immune modulation and tolerance induction using adeno-associated virus (AAV) gene therapy.
Our mission is to combine medical, scientific and technology skill-sets to discover new approaches to combat infectious disease outbreaks. We do this by listening to both patients and their healthcare providers to better prioritize problems and reveal unanticipated durable solutions.
Dr. Srivastava’s research has been focused on the following two parvoviruses, the non-pathogenic adeno-associated virus (AAV), and a common human pathogen, the parvovirus B19, and the development of recombinant parvovirus vectors for human gene therapy.
The primary mission is to merge molecular genetics research and health care by developing new therapeutic strategies involving gene transfer. The idea of gene therapy is a logical and natural progression of the last 20 years of research in medical genetics and molecular biology.
The Child Health Research Institute (CHRI) is designed to promote multidisciplinary research, provide a framework for collaborative projects and enhance collaboration among and between basic science and clinical faculty within the Department of Pediatrics and across the Health Science Center.
The Powell Gene Therapy Center (PGTC) at the University of Florida has been instrumental in the development of newer, safer agents for the delivery of therapeutic genes to patients with genetic diseases, such as cystic fibrosis (CF) and alpha 1-antitrypsin deficiency (AAT-D).
Our center has developed an interdisciplinary research program that integrates clinical, translational and basic research strategies that allows us to deliver quality services with compassion and excellence
UF Research Facilities
As a catalytic hub connecting resources, people and ideas, the CTSI expands collaboration and advances translational research across UF’s 16 colleges, the state and the national Clinical and Translational Science Award consortium.
Cores are centralized facilities or labs which offer shared services, shared equipment, resources and expertise to biomedical researchers and investigators on a fee-for-service basis.